Axsome Therapeutics Inc (AXSM)
Operating Cash Flow Growth
-1.63%
Quarterly · Period ending:
AXSM Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-1.63%period ending
Latest reported-1.63%period ending
AXSM Quarterly Cash from Operations YoY % (-66.51% → -1.63%)
Year-over-year change
High-resolution chart · PNG
AXSM operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -1.6316% | |
| 52.2767% | |
| 28.8108% | |
| 105.6143% | |
| -7.6818% | |
| 18.8752% | |
| 13.7013% | |
| 65.2069% | |
| 45.5997% | |
| -818.5192% | |
| -10.154% | |
| -135.2939% | |
| -65.0403% | |
| 82.1731% | |
| 4.4288% | |
| 15.0069% | |
| -32.0676% | |
| -19.9794% | |
| -40.3191% | |
| -70.1742% | |
| -34.391% | |
| -16.9393% | |
| -16.9997% | |
| -48.0636% | |
| -117.6427% | |
| -145.0013% | |
| -79.3674% | |
| -79.7505% | |
| -13.2317% | |
| -42.1944% | |
| -55.6762% | |
| 8.3036% | |
| -8.0417% | |
| -0.6632% | |
| 12.8237% | |
| -34.2546% | |
| -33.529% | |
| -68.1125% | |
| -220.6194% | |
| -149.803% | |
| -152.2589% | |
| -240.6485% | |
| -15.6126% | |
| -52.8695% | |
| -202.7227% | |
| -66.5114% |